Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Regulatory News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

22 Aug 2007 12:46

Bespak PLC22 August 2007 NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24. (2) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24. (3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24. (4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes in block capital letters. 1. Name of the issuer BESPAK PLC 2. State whether the notification relates to (i) a transaction notified inaccordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (asextended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) Both 3. Name of person discharging managerial responsibilities/director Mark Throdahl Director Paul Boughton Director Jon Glenn Director Joe Barry PDMR Keyvan Djamarani PDMR Chris Hall PDMR Kevin Burrow PDMR Jenny Owen Company Secretary 4. State whether notification relates to a person connected with a persondischarging managerial responsibilities/director named in 3 and identify theconnected person N/A 5. Indicate whether the notification is in respect of a holding of the personreferred to in 3 or 4 above or in respect of a non-beneficial interest THE NOTIFICATION IS IN RESPECT OF HOLDINGS OF THE PERSONS REFERRED TO IN 3 ABOVE 6. Description of shares (including class), debentures or derivatives orfinancial instruments relating to shares N/A 7. Name of registered shareholders(s) and, if more than one, the number ofshares held by each of them N/A 8. State the nature of the transaction N/A 9. Number of shares, debentures or financial instruments relating to sharesacquired N/A 10. Percentage of issued class acquired (treasury shares of that class shouldnot be taken into account when calculating percentage) N/A 11. Number of shares, debentures or financial instruments relating to sharesdisposed N/A 12. Percentage of issued class disposed (treasury shares of that class shouldnot be taken into account when calculating percentage) N/A 13. Price per share or value of transaction N/A 14. Date and place of transaction N/A 15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account whencalculating percentage) N/A 16. N/A If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17. Date of grant 21 August 2007 18. Period during which or date on which it can be exercised 21 August 2010 provided the applicable performance criteria have been satisfied 19. Total amount paid (if any) for grant of the option NIL 20. Description of shares or debentures involved (class and number) Grant of Performance Shares and Share Appreciation Rights (SARS) under theBespak plc 2005 LTIP in respect of ordinary 10p shares as follows Name Status Performance SARS Shares Mark Throdahl Director 18,000 105,000Jonathan Glenn Director 23,500 NilPaul Boughton Director 25,000 NilChris Hall PDMR 6,500 22,750Joe Barry PDMR 12,000 NilKeyvan Djamarani PDMR 11,500 NilKevin Burrow PDMR 12,500 NilJenny Owen Company Secretary 10,000 Nil 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at the time of exercise £6.61 22. Total number of shares or debentures over which options held followingnotification Name Status Performance SARS Share Shares Options Mark Throdahl Director 57,000 276,000 462,000Jonathan Glenn Director 49,500 Nil NilPaul Boughton Director 68,000 Nil NilChris Hall PDMR 25,000 42,250 82,000Joe Barry PDMR 24,000 Nil NilKeyvan Djamarani PDMR 34,500 Nil 16,500Kevin Burrow PDMR 12,500 Nil NilJenny Owen Company Secretary 16,000 Nil Nil 23. Any additional information NONE 24. Name of contact and telephone number for queries Jenny OwenCOMPANY SECRETARYTel 01908 525211 Name and signature of duly authorised officer of issuer responsible for makingnotification JENNY OWENDate of notification22 August 2007 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
25th Jul 20197:00 amRNSDirector/PDMR Shareholding
16th Jul 20193:49 pmRNSHolding(s) in Company
15th Jul 20197:00 amRNSIncident at the Aesica Cramlington API Facility
13th Jun 20197:00 amRNSFull Year results
29th May 20198:37 amRNSHolding(s) in Company
28th May 201912:50 pmRNSHolding(s) in Company
21st May 20194:30 pmRNSNotice of Results
15th Apr 20199:21 amRNSBlock listing Interim Review
1st Apr 20199:00 amRNSTotal Voting Rights
19th Mar 20199:14 amRNSHolding(s) in Company
7th Feb 20191:28 pmRNSAGM Voting Update - Director Declaration
31st Jan 20197:00 amRNSDEV610: FDA approval for Mylan's generic Advair
15th Jan 20193:03 pmRNSHolding(s) in Company
2nd Jan 20199:07 amRNSTotal Voting Rights
21st Dec 20187:00 amRNSClosure of American Depositary Receipt Programme
20th Dec 20188:56 amRNSHolding(s) in Company
11th Dec 20189:11 amRNSDirector/PDMR Shareholding
7th Dec 20189:16 amRNSHolding(s) in Company
6th Dec 20185:18 pmRNSDirector/PDMR Shareholding
4th Dec 20187:00 amRNSInterim Results
3rd Dec 20188:47 amRNSTotal Voting Rights
8th Nov 20183:49 pmRNSDirector/PDMR Shareholding
7th Nov 20182:49 pmRNSHolding(s) in Company
6th Nov 201812:30 pmRNSNotice of Results
6th Nov 20187:00 amRNSDirectorate Change
31st Oct 201811:17 amRNSDirector/PDMR Shareholding
15th Oct 20189:17 amRNSBlock listing Interim Review
10th Oct 20182:24 pmRNSDirector/PDMR Shareholding
9th Oct 201810:46 amRNSDirector/PDMR Shareholding
2nd Oct 201812:57 pmRNSDirector/PDMR Shareholding
1st Oct 20189:08 amRNSTotal Voting Rights
10th Sep 20187:00 amRNSDirector/PDMR Shareholding
10th Sep 20187:00 amRNSConsort Signs Development Agreements with Opiant
6th Sep 20183:47 pmRNSDirector/PDMR Shareholding
5th Sep 20184:41 pmRNSResult of AGM
3rd Sep 20188:20 amRNSTotal Voting Rights
23rd Aug 20184:51 pmRNSHolding(s) in Company
22nd Aug 20185:21 pmRNSDirector/PDMR Shareholding
9th Aug 20187:24 amRNSForm 8.5 (EPT/RI) Consort Medical Plc
9th Aug 20187:20 amRNSForm 8.5 (EPT/RI) - Carclo Plc
9th Aug 20187:00 amRNSDirector/PDMR Shareholding
8th Aug 20182:58 pmRNSForm 8.3 - Consort Medical Plc
7th Aug 20183:20 pmRNSForm 8.3 - Consort Medical plc
7th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
7th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
7th Aug 20189:43 amRNSStatement re withdrawal of Consort Medical plc
7th Aug 20188:23 amRNSConsort Medical No Intention to Bid for Carclo plc
6th Aug 20183:11 pmRNSForm 8.3 - Consort Medical PLC
6th Aug 20189:28 amRNSForm 8.3 - Consort Medical plc
3rd Aug 20183:08 pmRNSForm 8.3 - Consort Medical PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.